相关实验视频
Updated: Jul 3, 2025

06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
36.7K
由Aβ聚合生成的蓝色自发光照亮老年斑以及阿尔茨海默氏病的复杂血液和血管病理
Hualin Fu1,2,3, Jilong Li4, Chunlei Zhang4,5
1Institute of Nano Biomedicine and Engineering, School of Sensing Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China. hfu@sjtu.edu.cn.
Neuroscience bulletin
|February 12, 2024
概括
在阿尔茨海默病 (AD) 的大脑部分中,来自粉样β (Aβ) 聚合的蓝色自光是一种新的标志物. 这一发现揭示了Aβ自光作为阿尔茨海默病理学中的多氨基粉症的多功能指标.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 病理学 病理学 病理学
背景情况:
- 40年来已知的老年斑块蓝色自光,在阿尔茨海默氏症 (AD) 病理学方面被研究不足.
- 准确地解释AD大脑部分的核染色需要考虑斑块自光.
研究的目的:
- 为了研究老年斑块蓝色自光对阿尔茨海默病 (AD) 病理学的影响.
- 描述Aβ聚合产生的蓝色自光的来源和影响.
主要方法:
- 在阿尔茨海默氏症大脑部分上进行免疫组织化学和光成像.
- 在体外分析粉样β (Aβ) 聚合.
- 为了准确的核染色解释,减去蓝色斑块自光.
主要成果:
- 粉样蛋白-β (Aβ) 自 oligomers 和 Aβ / 血红蛋白异质复合体产生蓝色的自光.
- 来自Aβ聚合的蓝色自身光标记为老年斑块,红细胞聚合,脑粉样血管病变和血管异常.
- 对蓝色自光的纠正解决了神经元和 lysosomal 结构的误解.
结论:
- 由Aβ聚合生成的蓝色自光是阿尔茨海默病中的一个重要的多粉样性粉症标志物.
- 这种自发光可以让我们深入了解阿尔茨海默氏症中老年斑块以外的各种病理特征.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484

